
Axonilact SB 1000mg/500mg Injection
Marketer
Axonics Biotech
Salt Composition
Cefoperazone (1000mg) + Sulbactam (500mg)
Overview Axonilact SB 1000mg/500mg Injection
Combiflox SB, a 1000mg/500mg injectable formulation, combats diverse bacterial infections. Its mechanism inhibits microbial proliferation, thereby curbing infection spread. Administration must be strictly under medical guidance; adherence to the prescribed schedule is crucial. Complete the entire treatment course, regardless of symptom improvement; premature cessation may compromise efficacy. Nausea, vomiting, diarrhea, and dyspepsia are potential side effects; escalating symptoms necessitate immediate medical attention. Seek emergency care for allergic reactions (e.g., rash, pruritus, edema, dyspnea). Disclose all current medications to your physician before commencing treatment. Pregnant or lactating individuals require prior medical consultation. Alcohol consumption should be avoided due to potential additive drowsiness. While generally non-impairing to driving ability, refrain from driving if experiencing somnolence or vertigo. Adequate rest, nutritious food, and ample hydration promote faster recovery. Your doctor may order tests to monitor therapeutic response.
Uses of Axonilact SB 1000mg/500mg Injection
Combating Bacterial Infections
Major Benefits of Axonilact SB 1000mg/500mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Axonilact SB 1000mg/500mg Injection:
- Decreased white blood cell count (neutrophils)
- Decreased white blood cell count (lymphocytes)
- Decreased hemoglobin
- Decreased hematocrit level
- Low blood platelets
- Coagulation disorder
- Increased white blood cell count (eosinophils)
- Diarrhea
- Nausea
- Increased alanine aminotransferase
- Increased aspartate aminotransferase
- Increased alkaline phosphatase level in blood
- Vomiting
- Increased bilirubin in the blood
How to use Axonilact SB 1000mg/500mg Injection:
This medication will be administered by your healthcare provider; self-medication is strictly prohibited.
How Axonilact SB 1000mg/500mg Injection works:
Axonilact SB, a 1000mg/500mg injectable formulation, combines the antibiotic Cefoperazone with the beta-lactamase inhibitor Sulbactam. Cefoperazone's mechanism involves disrupting bacterial cell wall synthesis, a crucial process for bacterial viability. Sulbactam, by counteracting bacterial resistance enzymes, potentiates Cefoperazone's antibacterial effect.
SAFETY ADVICE
AlcoholUNSAFE
Ingestion of alcohol during Axonilact SB 1000mg/500mg Injection treatment may result in adverse effects including facial flushing, tachycardia, nausea, thirst, chest discomfort, and hypotension (a disulfiram-like reaction).
PregnancySAFE IF PRESCRIBED
Axonilact SB 1000mg/500mg Injection is typically regarded as safe for use during gestation. Preclinical trials in animals revealed minimal or no harmful consequences for fetal development; nevertheless, data from human trials are scarce.
Breast feedingSAFE IF PRESCRIBED
Axonilact SB 1000mg/500mg Injection poses no known breastfeeding risk. Research in humans indicates negligible transfer to breast milk, and no consequent harm to infants.
DrivingCONSULT YOUR DOCTOR
Axonilact SB 1000mg/500mg Injection's effect on driving ability is undetermined. Refrain from operating a vehicle if experiencing symptoms impairing concentration or reaction time.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding the administration of Axonilact SB 1000mg/500mg Injection to individuals with renal impairment. Physician consultation is advised.
LiverCONSULT YOUR DOCTOR
Data regarding the administration of Axonilact SB 1000mg/500mg Injection to individuals with hepatic impairment is scarce. Physician consultation is advised.
What if you forget to take Axonilact SB 1000mg/500mg Injection :
Should you omit a scheduled dose of Axonilact SB 1000mg/500mg Injection, seek immediate medical advice.
Facts to Know About Axonilact SB 1000mg/500mg Injection
| Label | Value |
|---|---|
| Potential for Dependence | None. |
| Treatment Category | Drugs combating infection |
